EVALUATION OF BACTERIAL COINFECTION IN PATIENTS WITH OTOMYCOSIS IN A TERTIARY CARE CENTRE
Main Article Content
Keywords
......
Abstract
Otomycosis is a common external ear infection frequently seen in tropical regions. While fungi are the primary pathogens, bacterial coinfections are increasingly recognized, complicating treatment outcomes.
Objectives: To identify the predominant fungal and bacterial species in otomycosis and to evaluate the coexistence of fungal and bacterial pathogens.
Methods: This prospective study included 130 clinically and microbiologically confirmed cases of otomycosis (aged 18–65 years) attending the ENT outpatient department of a tertiary care hospital in Chennai over six months. Fungal and bacterial isolates were identified using standard microbiological techniques.
Results: The majority of patients were aged 26–35 years (30.77%), with a slight female predominance (55.38%). Aspergillus niger was the most common fungus isolated (64.62%), followed by Candida spp. (21.54%). Bacterial growth was observed in 94.61% of samples, with Methicillin-Resistant Staphylococcus aureus (MRSA) (38.46%) and Pseudomonas aeruginosa (20%) being predominant. Notably, A. niger commonly coexisted with MRSA (23.81%) and Pseudomonas aeruginosa (22.62%), while Candida spp. were strongly associated with MRSA (71.43%).
References
2. Pontes ZBVDS, Silva ADF, Lima EDO, et al. Otomycosis: a retrospective study. Brazilian Journal of Otorhinolaryngology. 2009;75(3):367–370.
3. Fasunla J, Ibekwe T, Onakoya P. Otomycosis in western Nigeria. Mycoses. 2008;51(1):67–70.
4. Kurnatowski P, Filipiak A. Otomycosis: prevalence, clinical symptoms, therapeutic procedure. Mycoses. 2001;44(11-12):472– 479.
5. Pradhan B, Ratna Tuladhar N, Man Amatya R. Prevalence of otomycosis in outpatient department of otolaryngology in Tribhuvan University Teaching Hospital, Kathmandu, Nepal. Annals of Otology, Rhinology and Laryngology. 2003;112(4):384– 387.
6. Munguia R, Daniel SJ. Ototopical antifungals and otomycosis: a review. International Journal of Pediatric Otorhinolaryngology. 2008;72(4):453–459. doi: 10.1016/j.ijporl.2007.12.005. [DOI] [PubMed] [Google Scholar]
7. Fasunla J, Ibekwe T, Onakoya P. Otomycosis in western Nigeria. Mycoses. 2008;51(1):67–70.
8. Agarwal P, Devi LS. Otomycosis in a Rural Community Attending a Tertiary Care Hospital: Assessment of Risk Factors and Identification of Fungal and Bacterial Agents. J Clin Diagn Res. 2017 Jun;11(6):DC14-DC18.
9. Mofatteh MR, Naseripour Yazdi Z, Yousefi M, Namaei MH. Comparison of the recovery rate of otomycosis using betadine and clotrimazole topical treatment. Braz J Otorhinolaryngol. 2018 Jul-Aug;84(4):404-409.
10. Alarid-Coronel J, Celis-Aguilar E, Escobar-Aispuro L, Muñoz-Estrada V. Otomycosis in immunocompetent patients: Clinical and mycological features. Our experience with 40 cases. Clin Otolaryngol. 2018 Feb;43(1):373-377
11. Zaror L, Fischman O, Suzuki FA, Felipe RG (1991) Otomycosis in Sao Paulo. Rev Inst Med Trop Sao Paulo 33: 169-173.
12. Pradhan B, Tuladhar NR, Amatya RM (2003) Prevalence of otomycosis in outpatient department of otolaryngology in Tribhuvan University Teaching Hospital, Kathmandu, Nepal. Ann Otol Rhinol Laryngol 112: 384-387.
13. Ho T, Vrabec JT, Yoo D, Coker NJ (2006) Otomycosis: Clinical features and treatment implications. Otolaryngol Head Neck Surg 135: 787-791.
14. Paulose KO, Al Khalifa S, Shenoy P, Sharma RK (1989) Mycotic infection of the ear (otomycosis): A prospective study. J Laryngol Otol 103: 30-35.
15. Pontes ZB, Silva AD, Lima Ede O, Guerra Mde H, Oliveira NM, CarvalhoMde F, et al. Otomycosis: a retrospective study.Braz J Otorhinolaryngol. 2009;75(3):367–70
16. Kujundzic M, Braut T, Manestar D, et al; Water related otitis externa. Coll Antropol. 2012;36(3):893-7
17. Kaur R, Mittal N, Kakkar M, Agarwal AK, Mathur MD. Otomycosis-A clinico-mycological study. Ear Nose Throat J 2000;79(8):606-609.
18. Deshmukh J, Surpam R, Band A. Mycological study of aspergillus infections in otomycosis in eastern part of Maharashtra. Int J Health Sci Res. 2014;4(10):77-82.
19. Tasić-Otašević S, Golubović M, Đenić S, et al. Species distribution patterns and epidemiological characteristics of otomycosis in Southeastern Serbia. Journal de Mycologie Medicale. 2020 Sep;30(3):101011. DOI: 10.1016/j.mycmed.2020.101011
20. Sukumar B, Premamalini T, Shree SN, Kindo AJ. P022 luliconazole—a novel potent imidazole activity against Aspergillus niger and Aspergillus flavus causing otomycosis. Med Mycol. (2022) 60:22.
21. Collee JG, Miles RS, Watt B (1996) Tests for identification of bacteria. Mackie and McCartney practical medical microbiology 14: 131-149.
22. de Souza Costa P, Prado A, Bagon NP, Negri M, Svidzinski TIE. Mixed fungal biofilms: from mycobiota to devices, a new challenge on clinical practice. Microorganisms. (2022) 10:1721.
23. Hurst WB (2001) Outcome of 22 cases of perforated tympanic membrane caused by otomycosis. J Laryngol Otol 115: 879- 880.
24. Gharaghani, M., Seifi, Z. & Zarei Mahmoudabadi, A. Otomycosis in Iran: A Review. Mycopathologia 179, 415–424 (2015).
25. Brobby GW. The Discharging Ear in the Tropics: A Guide to Diagnosis and Management in the District Hospital. Tropical Doctor. 1992;22(1):10-13.
26. Bojanović M, Stalević M, Arsić-Arsenijević V, Ignjatović A, Ranđelović M, Golubović M, Živković-Marinkov E, Koraćević G, Stamenković B, Otašević S. Etiology, Predisposing Factors, Clinical Features and Diagnostic Procedure of Otomycosis: A Literature Review. J Fungi (Basel). 2023 Jun 13;9(6):662.
27. Görür K, İsmi O, Özcan C, Vayısoğlu Y. Treatment of Otomycosis in Ears with Tympanic Membrane Perforation is Easier with Paper Patch. Turk Arch Otorhinolaryngol. 2019 Dec;57(4):182-186
28. Chiller K, Selkin BA, Murakawa GJ. Skin microflora and bacterial infections of the skin. J Investig Dermatol Symp Proc. 2001 Dec;6(3):170-4. doi: 10.1046/j.0022-202x.2001.00043.x.
29. Hall RA, Noverr MC. Fungal interactions with the human host: exploring the spectrum of symbiosis. Curr Opin Microbiol. 2017 Dec;40:58-64.
30. Pawlowska TE. Symbioses between fungi and bacteria: from mechanisms to impacts on biodiversity. Curr Opin Microbiol. 2024 Aug;80:102496.
31. Wang, F., Xin, C., Liu, J. et al. Interactions between invasive fungi and symbiotic bacteria. World J Microbiol Biotechnol 36, 137 (2020).
32. Gomaa AA, Abou-Zied HA, Farhan SM, Bedaiwi RI, Alanazi MA, Glaeser SP, Kämpfer P, Abdelmohsen UR, Mokhtar FA, Abdelaleem ER. Apium graveolens-associated Aspergillus sp.: metabolomic profiling and anti-MRSA potential supported by in silico studies. Microb Cell Fact. 2025 Mar 8;24(1):57.
33. Abdellatief, H., Sehim, A.E., Emam, A.M. et al. Antimicrobial, antibiofilm and antioxidant activities of bioactive secondary metabolites of marine Scarus ghobban gut-associated Aspergillus niger: In-vitro and in-silico studies
34. Zhao J, Yu W. Interaction between Pseudomonas aeruginosa and Aspergillus fumigatus in cystic fibrosis. PeerJ. 2018 Nov 9;6:e5931
35. Todd OA, Fidel PL Jr, Harro JM, Hilliard JJ, Tkaczyk C, Sellman BR, Noverr MC, Peters BM. Candida albicans Augments Staphylococcus aureus Virulence by Engaging the Staphylococcal agr Quorum Sensing System. mBio. 2019 Jun 4;10(3):e00910- 19.
36. Fourie R, Ells R, Swart CW, Sebolai OM, Albertyn J, Pohl CH. Candida albicans and Pseudomonas aeruginosa Interaction, with Focus on the Role of Eicosanoids. Front Physiol. 2016 Feb 26;7:64.